Peripheral doses in radiotherapy: A comparison between IMRT, VMAT and Tomotherapy

Abstract The goal of this intercomparison is to determine the peripheral doses during treatment of prostate and head and neck (H&N) cancers. In the case of prostate cancer, two different treatment techniques are compared: intensity-modulated radiation therapy (IMRT – 10 MV and 18 MV), on a Varian Clinac 2100 C/D and Tomotherapy. VMAT (also on a Varian Clinac 2100 C/D) was compared to Tomotherapy, for H&N cancer. The treatment devices are located at the university hospitals of Leuven and Brussels, respectively. A common treatment protocol was agreed between the two clinical centers and this same protocol was used by each partner. For the higher energy modalities (10 MV and 18 MV) we also assessed the neutron contribution to the total dose, by using bubble detectors. In this way, the performance (in terms of peripheral doses) of the different treatment techniques, when faced with the same dose distribution constraints, was evaluated. The doses were evaluated with an anthropomorphic phantom loaded with TLD detectors. Summarizing our results, we can conclude that low energy radiation techniques, namely VMAT and Tomotherapy, have more interesting performances when compared to IMRT at energies of 10 MV and 18 MV, with respect to peripheral dose. On the one hand the former are associated with lower photon doses and, on the other hand, there is no contribution from neutrons to the total dose.

[1]  Firas Mourtada,et al.  The use of LiF (TLD‐100) as an out‐of‐field dosimeter , 2007, Journal of applied clinical medical physics.

[2]  R. Cloutier Tissue Substitutes in Radiation Dosimetry and Measurement. , 1989 .

[3]  R. Harrison,et al.  Organ doses from prostate radiotherapy and associated concomitant exposures. , 2006, The British journal of radiology.

[4]  Harald Paganetti,et al.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction , 2008, Physics in medicine and biology.

[5]  J. Balog,et al.  Helical tomotherapy radiation leakage and shielding considerations. , 2005, Medical physics.

[6]  Chester R. Ramsey,et al.  Out‐of‐field dosimetry measurements for a helical tomotherapy system† , 2006, Journal of applied clinical medical physics.

[7]  R. Mohan,et al.  The risk of developing a second cancer after receiving craniospinal proton irradiation , 2009, Physics in medicine and biology.

[8]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[9]  D. Kuban,et al.  The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.

[10]  R. Upreti,et al.  Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  P. Olko,et al.  Thermoluminescence Efficiency of LiF:Mg,Cu,P (MCP-N) Detectors to Photons, Beta-Electrons, Alpha Particles and Thermal Neutrons , 1994 .

[12]  Andrew K. Lee,et al.  Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[13]  M. Nieminen,et al.  The applicability of radiophotoluminescence dosemeter (RPLD) for measuring medical radiation (MR) doses. , 2012, Radiation protection dosimetry.

[14]  H. Paganetti,et al.  Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy , 2009, Physics in medicine and biology.

[15]  T. Kron,et al.  Assessment of leakage doses around the treatment heads of different linear accelerators. , 2012, Radiation protection dosimetry.

[16]  Hong-gi Kim,et al.  Determinants of Economic Threshold for Powdery Mildew on Cucumber , 2006 .

[17]  D Huyskens,et al.  Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. , 2004, Radiation protection dosimetry.